PCV50 Cost Effectiveness Analysis of Azilsartan Medoxomil and Chlorthalidone Fixed Dose Combination Therapy for Treatment of Hypertension

Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.653
https://www.valueinhealthjournal.com/article/S1098-3015(12)00718-8/fulltext
Title : PCV50 Cost Effectiveness Analysis of Azilsartan Medoxomil and Chlorthalidone Fixed Dose Combination Therapy for Treatment of Hypertension
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00718-8&doi=10.1016/j.jval.2012.03.653
First page : A121
Section Title : Cardiovascular Disorders
Open access? : No
Section Order : 129
Categories :
Tags :
Regions :
ViH Article Tags :